ACR Appropriateness Criteria radiologic management of hepatic malignancy.
暂无分享,去创建一个
Charles E Ray | Ghassan K Abou-Alfa | Michael D Darcy | Nicholas Fidelman | T. Kinney | B. Funaki | G. Abou-Alfa | F. Greene | W. Saad | C. Owens | S. Harrison | G. Vatakencherry | C. Ray | N. Fidelman | Thomas B Kinney | Stephen A Harrison | M. Darcy | A. Nemcek | Frederick L Greene | Brian E Kouri | Brian S Funaki | Charles T Burke | Jon K Kostelic | Jonathan M Lorenz | Ajit V Nair | Albert A Nemcek | Charles A Owens | Wael E A Saad | George Vatakencherry | J. Lorenz | C. Burke | J. Kostelic | B. Kouri | A. Nair | G. Vatakencherry | A. Nair | Frederick L Greene | Stephen A Harrison
[1] D. Nagorney,et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. , 2003, Journal of the American College of Surgeons.
[2] Joong-Won Park,et al. Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma. , 2012, Journal of hepatology.
[3] R. Salem,et al. Chemoembolization and Radioembolization for Metastatic Disease to the Liver: Available Data and Future Studies , 2012, Current Treatment Options in Oncology.
[4] G. Dodd,et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. , 2001, AJR. American journal of roentgenology.
[5] J. Charboneau,et al. Treatment of Neuroendocrine Cancer Metastatic to the Liver: The Role of Ablative Techniques , 2005, CardioVascular and Interventional Radiology.
[6] A. Benson,et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature , 1998, Cancer.
[7] W. Lau,et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. , 2007, Radiology.
[8] M. Valsecchi,et al. Prediction of progression‐free survival in patients presenting with hepatocellular carcinoma within the Milan criteria , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[9] G. Gores,et al. Liver transplantation for cholangiocarcinoma , 2010, Transplant international : official journal of the European Society for Organ Transplantation.
[10] Minshan Chen,et al. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma , 2009, Journal of Cancer Research and Clinical Oncology.
[11] Yong Zeng,et al. A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria , 2010, Annals of surgery.
[12] Kurinchi Gurusamy,et al. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. , 2010, Journal of hepatology.
[13] H. Pitt,et al. Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization? , 2008, Journal of Gastrointestinal Surgery.
[14] Angelo Andriulli,et al. Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials , 2009, The American Journal of Gastroenterology.
[15] M. Ychou,et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] V. Mazzaferro,et al. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. , 2011, Cancer treatment reviews.
[17] K. Delman,et al. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. , 2010, Journal of vascular and interventional radiology : JVIR.
[18] M. Reiser,et al. Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival , 2012, CardioVascular and Interventional Radiology.
[19] N. Pavlakis,et al. Management of Advanced Neuroendocrine Tumors With Hepatic Metastasis , 2009, Journal of clinical gastroenterology.
[20] V. Mazzaferro,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[21] Hongyu Zhou,et al. Radiofrequency ablation versus cryosurgery ablation for hepatocellular carcinoma: a meta-analysis. , 2013, Hepato-gastroenterology.
[22] K. Brown,et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. , 2008, Journal of vascular and interventional radiology : JVIR.
[23] Luigi Solbiati,et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.
[24] J. Gibbs,et al. Regional treatment of colorectal liver metastasis , 2010, Journal of surgical oncology.
[25] H-X Xu,et al. Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma. , 2011, The British journal of radiology.
[26] M. Barone,et al. Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma. , 2003, Hepato-gastroenterology.
[27] Robert C. G. Martin,et al. Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review. , 2012, Hepato-gastroenterology.
[28] T. de Baère,et al. Strategies for resection using portal vein embolization: metastatic liver cancer. , 2008, Seminars in interventional radiology.
[29] Ramon Planas,et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.
[30] R. J. Haas,et al. Bringing unresectable liver disease to resection with curative intent. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[31] T. Vogl,et al. Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study , 2009, CardioVascular and Interventional Radiology.
[32] C. Meyer,et al. Liver transplantation for cholangiocarcinoma: results in 207 patients. , 2000, Transplantation.
[33] S. Zangan,et al. Chemoembolization for hepatocellular carcinoma. , 2011, Seminars in roentgenology.
[34] Y. Shin,et al. Sorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analyses. , 2013, Radiology.
[35] W. Lees,et al. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. , 2008, Journal of vascular and interventional radiology : JVIR.
[36] D. Geller,et al. Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation , 2008, Annals of Surgical Oncology.
[37] E. Baudin,et al. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary , 2011, Neuroendocrinology.
[38] J. Furui,et al. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. , 2002, Surgery.
[39] M. Manns,et al. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. , 2002, Transplantation.
[40] Cynthia S. Johnson,et al. Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.
[41] J. Dancey,et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. , 2005, Journal of vascular and interventional radiology : JVIR.
[42] J. Geoghegan,et al. Treatment of colorectal liver metastases , 1999, The British journal of surgery.
[43] A. Benson,et al. Radioembolization of colorectal hepatic metastases using yttrium‐90 microspheres , 2009, Cancer.
[44] T. Pfammatter,et al. Transarterial Chemoembolization as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: An Evidence‐Based Analysis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[45] Thomas J Vogl,et al. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. , 2009, European journal of radiology.
[46] T. Pawlik,et al. Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Kenneth Hess,et al. Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.
[48] T. Chua,et al. Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option , 2010, Annals of surgical oncology.
[49] L. Ellis,et al. Significant Long-Term Survival After Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Patients with Cirrhosis , 2005, Annals of Surgical Oncology.
[50] P. Somasundar,et al. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. , 2010, Surgical oncology.
[51] S. Curley,et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] Christopher L Brace,et al. Microwave Ablation of Hepatic Malignancy , 2013, Seminars in Interventional Radiology.
[53] F. Xia,et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. , 2012, Journal of hepatology.
[54] S. Stavropoulos,et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. , 2007, Journal of vascular and interventional radiology : JVIR.
[55] I. Kamel,et al. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. , 2009, Journal of vascular and interventional radiology : JVIR.
[56] J. Berlin,et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.
[57] Zahra Kassam,et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] John Wong,et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.
[59] R. Schilsky,et al. Recommendations for management of patients with neuroendocrine liver metastases. , 2014, The Lancet. Oncology.
[60] P. Kim,et al. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. , 2011, AJR. American journal of roentgenology.
[61] Carlo Bartolozzi,et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. , 2005, Radiology.
[62] W. Lau,et al. The Current Role of Radiofrequency Ablation in the Management of Hepatocellular Carcinoma: A Systematic Review , 2009, Annals of surgery.
[63] N. Kemeny,et al. Regional hepatic chemotherapies in treatment of colorectal cancer metastases to the liver. , 2010, Seminars in oncology.
[64] W. Lau,et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma , 2009, Cancer.
[65] M. Guba,et al. Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[66] Hongzan Sun,et al. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials , 2013, European journal of gastroenterology & hepatology.
[67] M. Talamonti,et al. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. PART I: Diagnosis‐clinical staging and pathology , 2012, Journal of surgical oncology.
[68] M. Milas,et al. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. , 2007, Surgery.
[69] R. Wiesner,et al. Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.
[70] A. Tsung,et al. Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma. , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[71] M. Feng,et al. Radiation therapy for hepatocellular carcinoma. , 2011, Seminars in radiation oncology.
[72] I. Modlin,et al. article : somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine ( carcinoid ) tumours , 2009 .
[73] W. Lees,et al. Radiofrequency ablation of neuroendocrine liver metastases—the Middlesex experience , 2005, Abdominal Imaging.
[74] C. Georgiades,et al. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. , 2005, Journal of vascular and interventional radiology : JVIR.
[75] L. Berk,et al. Systemic therapy for advanced hepatocellular carcinoma: past, present, and future. , 2010, Cancer control : journal of the Moffitt Cancer Center.
[76] E. Vicaut,et al. Radiofrequency ablation of hepatocellular carcinoma: Long‐term results and prognostic factors in 235 Western patients with cirrhosis , 2009, Hepatology.
[77] A. Benson,et al. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. , 2013, Journal of vascular and interventional radiology : JVIR.
[78] K. Öberg,et al. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[79] L. Schwartz,et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] R. Dhanasekaran,et al. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC) , 2010, Journal of surgical oncology.
[81] K. Ahrar,et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors , 2005, Cancer.
[82] R. Arnold,et al. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. , 1996, Gut.
[83] Kenneth G. Thurston,et al. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. , 2004, Journal of vascular and interventional radiology : JVIR.
[84] M. Roček,et al. Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study , 2010, Annals of Surgical Oncology.
[85] C. Hammill,et al. Hepatic resection vs minimally invasive radiofrequency ablation for the treatment of colorectal liver metastases: a Markov analysis. , 2011, Archives of surgery.
[86] G. Klintmalm,et al. Long‐term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[87] Ming Shi,et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. , 2012, Radiology.
[88] A. Cucchetti,et al. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate. , 2013, Journal of hepatology.
[89] G. Gores,et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[90] J. Trojan,et al. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success , 2012, International journal of cancer.
[91] Ding‐Shinn Chen,et al. Percutaneous Ethanol Injection Versus Surgical Resection for the Treatment of Small Hepatocellular Carcinoma: A Prospective Study , 2005, Annals of surgery.
[92] T. Vogl,et al. Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications. , 2009, European journal of radiology.
[93] C. Nutting,et al. Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients , 2008, American journal of clinical oncology.
[94] C. Schade-Brittinger,et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[95] T. Pawlik,et al. Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury , 2013, CardioVascular and Interventional Radiology.
[96] W. Lau,et al. A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.
[97] K. Ahrar,et al. Update on the management of neuroendocrine hepatic metastases. , 2006, Journal of vascular and interventional radiology : JVIR.
[98] M. Soulen,et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. , 2004, Gastroenterology.
[99] J. Primrose,et al. Surgery for colorectal liver metastases , 2010 .
[100] N. Nicolay,et al. Liver metastases from colorectal cancer: radioembolization with systemic therapy , 2009, Nature Reviews Clinical Oncology.
[101] E. D. de Vries,et al. Everolimus for advanced pancreatic neuroendocrine tumors. , 2011, The New England journal of medicine.
[102] A. Benson,et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. , 2011, Gastroenterology.
[103] D. Breen,et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) , 2005, Gut.
[104] H. Blum,et al. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy , 2012, European journal of gastroenterology & hepatology.
[105] G. Gores,et al. Drop‐out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[106] A. Benson,et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. , 2001, Surgery.
[107] E. Wolin. The expanding role of somatostatin analogs in the management of neuroendocrine tumors. , 2012, Gastrointestinal cancer research : GCR.
[108] Junji Konishi,et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. , 2002, Radiology.
[109] M. Abecassis,et al. Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation , 2006, Journal of surgical oncology.
[110] M. Abecassis,et al. A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[111] Bruno Sangro,et al. Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges, and clinical perspectives , 2013, Hepatology.
[112] Y. Bang,et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. , 2011, The New England journal of medicine.
[113] T. Chua,et al. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[114] E. Abdalla. Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome , 2010, Journal of surgical oncology.
[115] T. de Baère,et al. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads. , 2012, Journal of hepatology.
[116] K. Herfarth,et al. Single-dose radiosurgical treatment for hepatic metastases - therapeutic outcome of 138 treated lesions from a single institution , 2013, Radiation oncology.
[117] G. M. Briggs,et al. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[118] C. Bartolozzi,et al. Percutaneous Radiofrequency Ablation of Hepatic Colorectal Metastases: Technique, Indications, Results, and New Promises , 2004, Investigative radiology.
[119] H. Rhim,et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies , 2009, Hepatology.
[120] Herb Chen,et al. Metastatic neuroendocrine hepatic tumors: resection improves survival. , 2006, Archives of surgery.
[121] D. Cunningham,et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. , 2010, The New England journal of medicine.
[122] J. Geschwind,et al. Intra-Arterial Therapies for Hepatocellular Carcinoma: Where Do We Stand? , 2010, Annals of Surgical Oncology.
[123] K. Thorlund,et al. Cryotherapy for hepatocellular carcinoma. , 2009, The Cochrane database of systematic reviews.
[124] N. Obuchowski,et al. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma. , 2011, Journal of vascular and interventional radiology : JVIR.
[125] T. Therneau,et al. Efficacy and Safety of Transarterial Radioembolization Versus Chemoembolization in Patients With Hepatocellular Carcinoma , 2013, CardioVascular and Interventional Radiology.
[126] Dieter Häussinger,et al. Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.
[127] H. Takaki,et al. Survival with up to 10-year follow-up after combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma: single-center experience. , 2013, Journal of vascular and interventional radiology : JVIR.
[128] R. Branch,et al. Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma , 2010, Cancer.
[129] A. Benson,et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. , 2010, Gastroenterology.
[130] W. Chapman,et al. Radiofrequency ablation for resectable colorectal hepatic metastases: is it time for a randomized controlled trial? , 2010, Annals of surgery.
[131] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[132] T. Hickish,et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.
[133] D. Morris,et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases , 2008, Cancer.
[134] Kenneth G. Thurston,et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. , 2005, Journal of vascular and interventional radiology : JVIR.
[135] M. Ducreux,et al. Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure , 2007, Annals of Surgical Oncology.
[136] W. Chapman,et al. Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation , 2008, Annals of surgery.
[137] K. Togashi,et al. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? , 2009, Radiology.
[138] E. Abdalla,et al. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. , 2005, Journal of vascular and interventional radiology : JVIR.
[139] E. Cholongitas,et al. Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies , 2007, CardioVascular and Interventional Radiology.
[140] Y. Maehara,et al. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. , 2007, Journal of the American College of Surgeons.